InCarda Therapeutics Finds $5M
San Francisco-based InCarda Therapeutics said Tuesday that it has raised $5M in a Series A funding, to go towards its therapies for acute cardiovascular conditions. The funding came from Morningside Ventures and angels. The company is developing drug delivery systems for trading cardiovascular conditions via inhaler. InCarda is led by Grace E. Colon, Ph.D.
posted on Wednesday, April 29, 2015 (Link to more information)
Related companies:
InCarda Therapeutics, Inc.
Related stories:
> Iconic Therapeutics Finds $20M
> Global Blood Therapeutics Finds $48M
> Global Blood Therapeutics Finds $40.7M For Sickle Cell Treatments
> SteadyMed Therapeutics Finds $3M In Working Capital
> Merck Buys Sirna Therapeutics
silicontap.com Home